Discover 3,556 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,556
Active & Responsive
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
Location: Los Angeles CA, Aurora CO, Houston TX, Madison WI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06428409
Phase1, Phase2, Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Los Angeles CA, Phoenix AZ, Palo Alto CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Motivation for IV Alcohol Self-Administration in Humans
for
Alcohol Use Disorder
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 21 - 65
Code: NCT06494891
Phase2, Recruiting
Active & Responsive
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
for
Post-Concussion Syndrome, Concussion, Brain,
Location: Westwood, Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18 - 65
Code: NCT06073886
Phase2, Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Los Angeles CA, La Jolla CA, Phoenix AZ, Stanford CA,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase2, Phase3, Recruiting
Active & ResponsiveNew
Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
for
Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation,
Location: Los Angeles CA, Minneapolis MN, Chicago IL, Boston MA
Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)
Sex: All
Age: 12 - 17
Code: NCT07286292
Phase2, Recruiting
Active & Responsive
Impact of Prebiotics in Ulcerative Colitis
for
Crohn Disease, Ulcerative Colitis
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18 - 70+
Code: NCT06495658
Recruiting
Active & Responsive
BBD Longitudinal Study of Osteogenesis Imperfecta
for
Osteogenesis Imperfecta
Location: Los Angeles CA, Phoenix AZ, Portland OR, Omaha NE,
Sponsor: Baylor College of Medicine
Sex: All
Age: 0+
Code: NCT02432625
Recruiting
Active & Responsive
Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients
for
Stroke, Hemorrhagic Stroke
Location: Los Angeles CA, Houston TX, Jacksonville FL,
Sponsor: EMVision Medical Devices Ltd
Sex: All
Age: 22+
Code: NCT06999122
Recruiting
Active & Responsive
Human Laboratory Study of Apremilast for Alcohol Use Disorder
for
Alcohol Use Disorder, Alcohol Misuse
Location: Los Angeles CA, Aurora CO, Charlottesville VA
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sex: All
Age: 21+
Code: NCT07325266
Phase2, Recruiting
Active & Responsive
PiMZ Longitudinal Cohort (PiMZ Logic)
for
Alpha 1-Antitrypsin Deficiency, Emphysema or COPD
Location: Los Angeles CA
Sponsor: Columbia University
Sex: All
Age: 18+
Code: NCT06505603
Recruiting
Active & Responsive
Suvorexant for Treatment of AUD and PTSD
for
Alcohol Use Disorder (AUD),
Location: Los Angeles CA, Houston TX
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Sex: All
Age: 21 - 65
Code: NCT06679062
Phase2, Recruiting
Active & Responsive
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
for
Sickle Cell Disease
Location: Los Angeles CA, Milwaukee WI, Gainesville FL,
Sponsor: New York Medical College
Sex: All
Age: 0 - 21
Code: NCT02675959
Phase2, Recruiting
Active & Responsive
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Los Angeles CA, San Francisco CA, Aurora CO,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT05533697
Phase1, Phase2, Recruiting
Active & Responsive
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
for
Melanoma, Unresectable Melanoma
Location: Los Angeles CA, New York NY, Boston MA
Sponsor: NYU Langone Health
Sex: All
Age: 18 - 70+
Code: NCT05428007
Phase2, Recruiting
Active & Responsive
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
for
Breast Neoplasms, Breast Cancer
Location: Santa Monica CA, Tigard OR, Billings MT, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06797635
Phase2, Recruiting
Active & Responsive
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
for
EDS, Cataplexy, Fatigue, Narcolepsy
Location: Los Angeles CA, Peoria AZ, Redwood City CA,